Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antimicrobials
Agion Technologies Expands Global Regulatory Approval Portfolio with Approvals by US EPA, NSF, and EU EFSA
February 2nd, 2008
Agion Technologies, the leader in naturally-safe, silver-based antimicrobial solutions announced the company has secured additional regulatory approvals for specific formulations from government agencies in the U.S. and Switzerland. The Environmental Protection Agency (EPA) has granted approval for the Agion formulation for use in medical devices, equipment, and supplies. This clears the path for the Agion antimicrobial technology to be incorporated directly into various materials including plastics, fibers, coatings, films, and laminates for use in the healthcare industry. The EPA registration for this market will enable additional manufacturers to incorporate Agion's...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2008-02-02)
|
